A place for those managing the ups & downs of a Stage IV/metastatic breast cancer diagnosis. Please respect that this forum is for Stage IV members only. There is a separate forum For Family and Caregivers of People with a STAGE IV Diagnosis.
Posted on: Aug 27, 2020 12:18PM
The DESTINY-Breast02 trial is a phase III trial for people diagnosed with metastatic HER2-positive breast cancer or other stages of HER2-positive disease that can't be removed with surgery and have been previously treated with Kadcyla (chemical name: T-DM1 or ado-trastuzumab emtansine).
The trial is looking to see if the medicine fam-trastuzumab-deruxtecan-nxki offers more benefits than either Herceptin (chemical name: trastuzumab) and Xeloda (chemical name: capecitabine) or Tykerb (chemical name: lapatinib) and Xeloda.